Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside

Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside Suppliers list
Company Name: T&W GROUP  
Tel: 021-61551611 13296011611
Email: contact@trustwe.com
Company Name: Amadis Chemical Company Limited  
Tel: 571-89925085
Email: sales@amadischem.com
Company Name: Zhengzhou Granlen Sciences, ltd.  
Tel: 0371-85513397 +86-18610099868
Email: info@granlen.com
Company Name: NewCan Biotech Limited  
Tel: +86-571-86912261 19975279805
Email: sales@newcanbio.com
Company Name: SHANGHAI T&W PHARMACEUTICAL CO., LTD.  
Tel: +86-021-61551413
Email: contact@trustwe.com

Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside manufacturers

Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside Basic information
Product Name:Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside
Synonyms:9-(3',5'-Di-O-benzoyl-2'-deoxy-2'-fluoro-β-Darabinofuranosyl)-9H-purine;9-(3,5-Di-O-benzoyl-2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purine;Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside;9H-Purine, 9-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-;Purine-9-β-D-(3’,5’-di-O-benzoyl-2’-deoxy-2’-fluoro)arabinoriboside;Purine-9-b-D-(3’,5’-di-O-benzoyl-2’-deoxy-2’-fluoro)arabinoriboside;Purine-9-beta-D-(3’,5’-di-O-benzoyl-2’-deoxy-2’-fluoro)arabinoriboside
CAS:132723-01-4
MF:C24H19FN4O5
MW:462.44
EINECS:
Product Categories:
Mol File:132723-01-4.mol
Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside Structure
Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside Chemical Properties
Boiling point 643.9±65.0 °C(Predicted)
density 1.45±0.1 g/cm3(Predicted)
pka2.42±0.10(Predicted)
Safety Information
MSDS Information
Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside Usage And Synthesis
UsesPurine-9-b-D-(3’,5’-di-O-benzoyl-2’-deoxy-2’-fluoro)arabinoriboside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
References[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005
Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside Preparation Products And Raw materials
Tag:Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside(132723-01-4) Related Product Information
Uridine Raltitrexed Capecitabine 6-Mercaptopurine Clofarabine 4-Thiouridine